Search

everythinglearnresearchcommunity

for

Search:↓

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Agmatine may help reduce seizures linked to hormone changes in female rats.

High doses of progesterone can reduce seizures in mice.

The 1:5 ratio of fragrant pandan to celery extract best promotes hair growth.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Diphenyl cresyl phosphate has low toxicity but can harm the liver, kidneys, adrenal glands, and testicles at high doses.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

CTP-543 is generally safe for treating alopecia areata.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Balancing lipophilicity and solubility is key for effective and safe ketorolac prodrugs.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Stopping finasteride improved seizure control, suggesting neurosteroids affect seizures and treatment.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Phenobarbitone can cause severe and sometimes fatal skin reactions.

ATP helps prevent skin damage from vandetanib by reducing stress.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Optimized liposomes can improve drug delivery and effectiveness.

Levetiracetam and valproate sodium both reduce seizures when added to lamotrigine, but levetiracetam has fewer side effects.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.